Liraglutide baseline data needed
HbA1C q 6 months
Renal/Lipid values prn
Can the patient tolerate injections
Liraglutide Monitoring and assessment
Signs of
Cholecystitis
Pancreatitis
depression
Suicidal thoughts
Phentermine On-going assessment with long term use
cardiac assessment
Toprimate
Causes sense of satiety
If weight loss of 5% has not occurred in 6 months, discontinue
If 3% has occurred by 3 months increase dose
What would happen if Lorcaserin is given with at CYP2D6 substrate?
Increased serum level of substrate
Prescribe substrate at lower doses
Which weight loss drug could cause hypothyroidism in a pt taking levothyroxine
Orlistat
Naltrexone/Bupropion (Contrave) Baseline data needed
Blood glucose
Liver function
Renal function
Mental status
On going assessment with Naltrexone/Bupropion
Blood sugar
Liver/Renal
S/s of depression, anxiety, SI, mania, panic attacks
Which weight loss drugs are associated with increased suicide risk in
children/adolescent/young adults
Contrave (naltrexone/bupropion)
Naltrexone/Bupropion Patient education
Decreases ability of opioid analgesics to relieve pain
How to discontinue phetermine and/or topiramate
Gradually, withdrawal sx including seizure may occur with abrupt discontinuation
Lorcaserin baseline data needed:
Rule out
Pulmonary HTN
Valvular disease
Lorcaserin On going assessment
Cognitive changes
CBC with diff (Blood dyscrasias)
Phetermine Baseline data needed
, Cardiac assessment
Ongoing Monitoring/assessment for Phetermine
Cardiac assessment
Lorcaserin patient education:
Increased r/o hypoglycemia in DM
Do not take in pregnancy
Do not increase insulin doses
Orlistat Patient Education
Stools may be oily
Fecal incontinence may occur
Take a Vitamin with A,D,E & K (fat soluble)
Levothyroxine/Orlistat taken 4 hours apart
Warfarin should be decreased
Take with food
Fat should be 30% of oral intake
BMI level that bariatric surgery should be considered
>35
Obesity Stage 0
BMI 25 or > with no complications
Treat with lifestyle modifications
If not successful add drugs
Obesity Stage 1
BMI 25 or > with 1 or more mild/moderate complication
Treat with lifestyle modifications
Drugs if unsuccessful or BMI 27 or >
Obesity Stage 2
BMI 25 or > with 1 complication requiring significant weight loss
Consider drugs for BMI 25-26
Prescribe drugs for BMI 27 or >
Schedule IV weight loss drugs
Lorcaserin
Diethylproprion
Phentermine/toprimate
DM Type II, Gallbladder disease, Gout, Fatty liver are complications of
BMI between 30-40
Metroniadazole Patient teaching
Avoid alcohol
May cause a metallic taste
Avoid in 1st trimester of pregnancy
Monitoring needs for long-term antifungal use
Liver function &
Alkaline phosphate
Which anthelmintic drugs is safe to prescribe without obtaining baseline data
Pyrantel Pamoate
Which anthelmintic drug causes bone marrow suppression and liver impairment
Albendazole and Mebendazole
HbA1C q 6 months
Renal/Lipid values prn
Can the patient tolerate injections
Liraglutide Monitoring and assessment
Signs of
Cholecystitis
Pancreatitis
depression
Suicidal thoughts
Phentermine On-going assessment with long term use
cardiac assessment
Toprimate
Causes sense of satiety
If weight loss of 5% has not occurred in 6 months, discontinue
If 3% has occurred by 3 months increase dose
What would happen if Lorcaserin is given with at CYP2D6 substrate?
Increased serum level of substrate
Prescribe substrate at lower doses
Which weight loss drug could cause hypothyroidism in a pt taking levothyroxine
Orlistat
Naltrexone/Bupropion (Contrave) Baseline data needed
Blood glucose
Liver function
Renal function
Mental status
On going assessment with Naltrexone/Bupropion
Blood sugar
Liver/Renal
S/s of depression, anxiety, SI, mania, panic attacks
Which weight loss drugs are associated with increased suicide risk in
children/adolescent/young adults
Contrave (naltrexone/bupropion)
Naltrexone/Bupropion Patient education
Decreases ability of opioid analgesics to relieve pain
How to discontinue phetermine and/or topiramate
Gradually, withdrawal sx including seizure may occur with abrupt discontinuation
Lorcaserin baseline data needed:
Rule out
Pulmonary HTN
Valvular disease
Lorcaserin On going assessment
Cognitive changes
CBC with diff (Blood dyscrasias)
Phetermine Baseline data needed
, Cardiac assessment
Ongoing Monitoring/assessment for Phetermine
Cardiac assessment
Lorcaserin patient education:
Increased r/o hypoglycemia in DM
Do not take in pregnancy
Do not increase insulin doses
Orlistat Patient Education
Stools may be oily
Fecal incontinence may occur
Take a Vitamin with A,D,E & K (fat soluble)
Levothyroxine/Orlistat taken 4 hours apart
Warfarin should be decreased
Take with food
Fat should be 30% of oral intake
BMI level that bariatric surgery should be considered
>35
Obesity Stage 0
BMI 25 or > with no complications
Treat with lifestyle modifications
If not successful add drugs
Obesity Stage 1
BMI 25 or > with 1 or more mild/moderate complication
Treat with lifestyle modifications
Drugs if unsuccessful or BMI 27 or >
Obesity Stage 2
BMI 25 or > with 1 complication requiring significant weight loss
Consider drugs for BMI 25-26
Prescribe drugs for BMI 27 or >
Schedule IV weight loss drugs
Lorcaserin
Diethylproprion
Phentermine/toprimate
DM Type II, Gallbladder disease, Gout, Fatty liver are complications of
BMI between 30-40
Metroniadazole Patient teaching
Avoid alcohol
May cause a metallic taste
Avoid in 1st trimester of pregnancy
Monitoring needs for long-term antifungal use
Liver function &
Alkaline phosphate
Which anthelmintic drugs is safe to prescribe without obtaining baseline data
Pyrantel Pamoate
Which anthelmintic drug causes bone marrow suppression and liver impairment
Albendazole and Mebendazole
